Efficacy of Non-Steroidal Anti-Inflammatory Drugs before cystoscopy

Efficacy of Non-Steroidal Anti-Inflammatory Drugs before cystoscopy - NSAIDS for cystoscopy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000000979

Enrollment

Registered

2008-02-28

Start date

2006-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urothelial cancer

Interventions

25 cases no-drug at 1st cystoscopy-&gt

3 months-&gt

Zaltoprofen at 2nd cystostopy-&gt

Loxoprofen at 3rd cystoscopy 25 cases no-drug at 1st cystoscopy-&gt

Loxoprofen at 2nd cystostopy-&gt

Zaltoprofen at 3rd cystoscopy

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Patients who under follow-up by periodic cystoscopy for urothelial cancer after treatment without chemotherapy

Exclusion criteria

Exclusion criteria: those who are under chemotherapy those who are contraindication for Zaltoprofen or Loxoprofen

Design outcomes

Primary

Measure	Time frame
We analyze whether pain associated with cystocopy can be decreased or not	—

Secondary

Measure	Time frame
If pain is decreased, we analyze which drug is more potent, which order is better, or whether patients hope to continue taking drugs before cystoscopy	—

Countries

Japan

Contacts

Public ContactAkira Komiya

University of Toyama Department of Urology

akirakomiya@mac.com

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026